Operating revenue of Starry Pharmaceutical 2020-2022
In 2022, the Chinese pharmaceutical firm Starry Pharmaceutical generated more than two billion yuan of revenue, representing a growth of 130 million yuan from the previous year. Although a relatively small company in the industry, Starry is one of the most important manufacturers of radiocontrast agents in China.